A bill put forward by Senate Majority leader Chuck Schumer, D-NY, to decriminalize marijuana includes language on CBD that has been welcomed by supplement industry stakeholders.
In FoodNavigator-USA's latest roundup of new product launches, we include Clif Bar's first foray into boxed cereals, PeaTos' fiber- and protein-fueled take on Doritos, RXBARS's new plant-based bars, and a wave of products focusing...
The publication of a recent FDA priorities list that omitted the hemp/CBD question is a reminder that a legislative solution is the only practical way forward for a regulatory resolution for these ingredients, advocates say.
Months ago, many may not have even been aware of the existence of this cannabis compound. Today, Delta-8 is the fastest-growing category of hemp products, with US sales of products listing Delta-8 jumping 144% from a year earlier, according to cannabis...
The CBD sports nutrition sector had its game significantly boosted in 2018 when the World Anti-Doping Agency (WADA) removed the hemp-derived cannabinoid from its list of banned performance-enhancing substances – the market duly took off.
The COVID-19 pandemic and ongoing legal quagmire surrounding CBD supplements and foods in the US have knocked what was a booming category – along with scarce science and raw material pricing and QC concerns – but the sector is looking to economic and...
Royal DSM has entered into a broad commercial partnership with Colorado-based cannabinoid company Mile High Labs (MHL) for next generation science-backed cannabinoid solutions.
With US retail sales of cannabidiol-infused foods, beverages and supplements declining sharply in the past year and some early-adopters souring on the ingredient after experiencing lackluster ‘results,’ some players in the space are discontinuing their...
Kombucha market leader GT’s Living Foods has withdrawn its CBD-infused Dream Catcher functional beverage line, with founder GT Dave acknowledging that regulatory uncertainty and a slightly confused consumer proposition both played a role.
A US Senate bill to specifically allow the use of CBD and other hemp derivatives in dietary supplements and foods has been introduced with bipartisan sponsorship. The bill also enjoys broad support within the industry.
A marketer of CBD products has agreed in a Federal Trade Commission administrative proceeding to cease making unsubstantiated disease treatment claims and pay more than $30,000 in consumer redress.
CBD products manufacturer CV Sciences has recorded a sharp decline in revenue, mirroring reports of an overall contraction in the market for hemp extract products.
In a sign of further consolidation within the CBD/hemp products industry, THC Farmaceuticals Inc has announced it has acquired a contract manufacturer in Southern California.
